| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,032 |
6,051 |
$551K |
| S0281 |
Medical home program, comprehensive care coordination and planning, maintenance of plan |
1,467 |
1,454 |
$359K |
| S0280 |
Medical home program, comprehensive care coordination and planning, initial plan |
857 |
803 |
$259K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,381 |
2,143 |
$134K |
| 86328 |
|
1,509 |
1,416 |
$60K |
| 99215 |
Prolong outpt/office vis |
485 |
452 |
$53K |
| 99000 |
|
4,309 |
3,995 |
$37K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,415 |
1,352 |
$20K |
| 36415 |
Collection of venous blood by venipuncture |
3,039 |
2,838 |
$12K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
906 |
834 |
$11K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
120 |
117 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
990 |
811 |
$11K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
116 |
112 |
$10K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
163 |
161 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
212 |
198 |
$7K |
| 99205 |
Prolong outpt/office vis |
45 |
45 |
$6K |
| 87400 |
|
438 |
428 |
$5K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
55 |
54 |
$4K |
| 96127 |
|
749 |
730 |
$4K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
368 |
341 |
$4K |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
21 |
12 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
130 |
127 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
22 |
22 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
16 |
15 |
$1K |
| 92551 |
|
142 |
138 |
$983.42 |
| 90461 |
|
89 |
85 |
$786.77 |
| 0001A |
|
77 |
75 |
$621.98 |
| 81000 |
|
151 |
148 |
$511.30 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
13 |
12 |
$323.10 |
| 90715 |
|
12 |
12 |
$256.40 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
30 |
26 |
$250.02 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
174 |
163 |
$214.25 |
| 93000 |
|
26 |
25 |
$198.99 |
| 99173 |
|
104 |
103 |
$191.16 |
| 0002A |
|
21 |
19 |
$180.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
70 |
46 |
$43.00 |
| G0506 |
Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) |
35 |
27 |
$41.37 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
12 |
12 |
$11.65 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
18 |
14 |
$4.06 |